Two pilot studies of AHR-1680 in chronic schizophrenic patients.
D000328:Adult; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006801:Humans; D007659:Ketones / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010080:Oxazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D011605:Psychoses, Substance-Induced; D012559:Schizophrenia / Q000188:drug therapy*; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced
D007659:Ketones; D010080:Oxazoles; D010919:Placebos